First Report of NDM and VIM Coproducing


Journal

Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 31 7 2019
medline: 21 3 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Metallo-β-lactamase (MBL) producing bacteria constitute nowadays a serious global concern worldwide. The purpose of our present study was to characterize molecular features of MBL producing bacteria and to identify the existing clones in our area. Thirteen MBL-producing-

Identifiants

pubmed: 31361568
doi: 10.1089/mdr.2019.0115
doi:

Substances chimiques

Anti-Bacterial Agents 0
VIM-1 metallo-beta-lactamase EC 3.5.2.-
beta-Lactamases EC 3.5.2.6
beta-lactamase NDM-1 EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1282-1286

Auteurs

Raoudha Dziri (R)

Laboratory of Microorganisms and Active Biomolecules, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Imen Ayari (I)

Laboratory of Microorganisms and Active Biomolecules, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Farouk Barguellil (F)

Service of Microbiology, Military Hospital of Tunis HMPIT, Tunis, Tunisia.
Department of Microbiology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.

Hadda-Imen Ouzari (HI)

Laboratory of Microorganisms and Active Biomolecules, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Mohamed Selim El Asli (MS)

Service of Microbiology, Military Hospital of Tunis HMPIT, Tunis, Tunisia.
Department of Microbiology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.

Naouel Klibi (N)

Laboratory of Microorganisms and Active Biomolecules, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH